Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 5
2007 23
2009 1
2011 3
2012 4
2013 6
2014 7
2015 5
2016 6
2017 4
2018 2
2019 5
2020 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Results by year
Filters applied: . Clear all
Page 1
A Comprehensive Review of Pegvaliase, an Enzyme Substitution Therapy for the Treatment of Phenylketonuria.
Hydery T, Coppenrath VA. Hydery T, et al. Drug Target Insights. 2019 Jun 21;13:1177392819857089. doi: 10.1177/1177392819857089. eCollection 2019. Drug Target Insights. 2019. PMID: 31258325 Free PMC article. Review.
Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies.
Abdul Manap AS, Vijayabalan S, Madhavan P, Chia YY, Arya A, Wong EH, Rizwan F, Bindal U, Koshy S. Abdul Manap AS, et al. Drug Target Insights. 2019 Jul 31;13:1177392819866412. doi: 10.1177/1177392819866412. eCollection 2019. Drug Target Insights. 2019. PMID: 31391778 Free PMC article. Review.
Basic Concepts in Genetics and Pharmacogenomics for Pharmacists.
Orrico KB. Orrico KB. Drug Target Insights. 2019 Dec 3;13:1177392819886875. doi: 10.1177/1177392819886875. eCollection 2019. Drug Target Insights. 2019. PMID: 31832012 Free PMC article. Review.
Paradoxical bronchoconstriction caused by β2-adrenoceptor agonists.
Ayed K, Khalifa ILH, Mokaddem S, Jameleddine SBK. Ayed K, et al. Drug Target Insights. 2020 Oct 5;14:12-15. doi: 10.33393/dti.2020.2188. eCollection 2020. Drug Target Insights. 2020. PMID: 33132694 Free PMC article.
Prevalence of multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing gram-negative bacilli: A meta-analysis report in Ethiopia.
Abayneh M, Worku T. Abayneh M, et al. Drug Target Insights. 2020 Oct 5;14:16-25. doi: 10.33393/dti.2020.2170. eCollection 2020. Drug Target Insights. 2020. PMID: 33132695 Free PMC article. Review.
Vernakalant in Atrial Fibrillation: A Relatively New Weapon in the Armamentarium Against an Old Enemy.
Kossaify A. Kossaify A. Drug Target Insights. 2019 Jul 3;13:1177392819861114. doi: 10.1177/1177392819861114. eCollection 2019. Drug Target Insights. 2019. PMID: 31320795 Free PMC article. Review.
Targeting Streptococcus pneumoniae UDP-glucose pyrophosphorylase (UGPase): in vitro validation of a putative inhibitor.
Sharma M, Sharma S, Ray P, Chakraborti A. Sharma M, et al. Drug Target Insights. 2020 Oct 7;14:26-33. doi: 10.33393/dti.2020.2103. eCollection 2020. Drug Target Insights. 2020. PMID: 33132696 Free PMC article.
P-glycoprotein Inhibition for Optimal Drug Delivery.
Amin ML. Amin ML. Drug Target Insights. 2013 Aug 19;7:27-34. doi: 10.4137/DTI.S12519. Drug Target Insights. 2013. PMID: 24023511 Free PMC article. Review.
Omalizumab as a Provoking Factor for Venous Thromboembolism.
Oblitas CM, Galeano-Valle F, Vela-De La Cruz L, Del Toro-Cervera J, Demelo-Rodríguez P. Oblitas CM, et al. Drug Target Insights. 2019 Jul 4;13:1177392819861987. doi: 10.1177/1177392819861987. eCollection 2019. Drug Target Insights. 2019. PMID: 31320796 Free PMC article.
DRESS Syndrome and Daclizumab Failure-Were Potentially Dangerous Signs Missed in Clinical Trials?
Avasarala J. Avasarala J. Drug Target Insights. 2018 Jun 29;12:1177392818785136. doi: 10.1177/1177392818785136. eCollection 2018. Drug Target Insights. 2018. PMID: 30013311 Free PMC article.
75 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page